Stock PURCHASE AGREEMENT AND LETTER OF INVESTMENT INTENTStock Purchase Agreement • September 2nd, 2020 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Ohio
Contract Type FiledSeptember 2nd, 2020 Company Industry JurisdictionThis Registration AND INDEMNIFICATION Agreement (“Agreement”), effective as of August 31, 2020, is made by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Keystone Capital Partners, LLC, a Delaware limited liability company (“Investor”). Capitalized terms used but not defined herein have the meanings given in the SPA (as defined below).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 2nd, 2020 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 2nd, 2020 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is made and entered into as of August 30, 2020, by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule I hereto (each an “Investor”, and collectively, the “Investors”).